National Health Investors Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
National Health Investors, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue335.18319.84278.19298.72332.81318.08294.61
Cost of Revenue11.1711.519.7911.649.657.351.17
Gross Profit324.02319.84268.41287.08323.16310.73293.45
Operating Expenses
Research & Development0.000.000.000.000.000.000.00
Selling, General & Administrative21.7930.8125.3218.4314.5613.9112.86
Operating Expenses140.16200.88135.64216.1499.2394.7184.21
Operating Income183.86-51.98132.77-34.04223.93217.57209.24
Other Income/Expense
Interest Income0.000.000.000.000.000.000.00
Interest Expense56.1255.5142.4448.1149.5352.7345.74
Other Income/Expense12.64-249.73-22.44-300.4414.27-0.82-5.85
Income
Income Before Tax136.59134.3865.41242.35185.31160.45154.33
Income Tax Expense-0.05-0.20-0.10-0.100.000.000.00
Net Income137.99135.6566.40111.80185.13160.46154.33
Net Income - Continuous Operations136.64134.3865.50111.970.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA264.16249.02178.73240.94318.00290.00271.42
EBIT192.71179.05107.85160.15234.85213.18200.07
Depreciation & Amortization71.4469.9770.8880.8083.1576.8271.35
Earnings Per Share
Basic EPS3.003.001.002.004.004.004.00
Diluted EPS3.003.001.002.004.004.004.00
Basic Shares Outstanding43.8443.3944.7745.7144.7043.4241.94
Diluted Shares Outstanding44.1043.3944.7945.7344.7043.7042.09